Business Coach
9562
Daiwa Cycle
5888
Liberta
4935
Heartseed
219A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.61%13.86B | 8.56%3.77B | 13.10%3.74B | 11.54%3.3B | 18.63%3.06B | 5.64%12.31B | 6.58%3.47B | 10.28%3.31B | 6.98%2.96B | -2.20%2.58B |
Cost of revenue | 11.82%10.59B | 12.67%2.92B | 18.39%2.88B | 5.57%2.49B | 10.16%2.3B | 10.48%9.47B | 7.47%2.59B | 15.31%2.44B | 13.93%2.36B | 5.41%2.09B |
Gross profit | 15.22%3.27B | -3.53%849.36M | -1.73%853.18M | 34.97%811.17M | 54.89%755.9M | -7.85%2.84B | 4.04%880.4M | -1.74%868.21M | -13.68%601.01M | -25.28%488.03M |
Operating expense | 16.88%2.95B | 16.95%791.41M | 17.15%756.11M | 22.49%728.03M | 11.01%673.63M | 1.96%2.52B | -14.63%676.71M | -7.17%645.42M | 19.22%594.36M | 24.25%606.84M |
Operating profit | 1.94%320.41M | -71.55%57.94M | -56.43%97.06M | 1,150.60%83.14M | 169.24%82.27M | -47.99%314.31M | 280.23%203.69M | 18.32%222.79M | -96.64%6.65M | -172.12%-118.82M |
Net non-operating interest income (expenses) | -25.26%-14.1M | -77.56%-3.93M | -37.25%-4.32M | -22.28%-2.9M | 16.23%-2.96M | -8.45%-11.26M | 32.96%-2.22M | 6.90%-3.14M | -14.83%-2.37M | -115.57%-3.53M |
Non-operating interest income | -58.40%161K | -368.38%-365K | 265.87%461K | -178.67%-59K | 148.00%124K | 24.44%387K | -49.63%136K | 185.71%126K | --75K | --50K |
Non-operating interest expense | 22.48%14.27M | 51.77%3.57M | 46.06%4.78M | 16.11%2.84M | -13.93%3.08M | 8.91%11.65M | -34.22%2.35M | 1.24%3.27M | 8.57%2.45M | 118.62%3.58M |
Net investment income | 2.24M | |||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -54.13M | -46.83M | 0 | 0 | -7.3M | 0 | 0 | 0 | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 102.83%7.33M | 64.20%-5.56M | -209.89%-8.46M | -535.65%-259.29M | 65.72%-15.52M | -2.48%-2.73M | ||||
Less:Other special charges | -121.63%-7.33M | -64.20%5.56M | 209.89%8.46M | ---- | ---- | 1,995.36%33.9M | --15.52M | --2.73M | ---- | ---- |
Less:Write off | --0 | --0 | ---- | ---- | ---- | 416.42%225.39M | --0 | --0 | ---- | ---- |
Other non-operating income (expenses) | 33.43%-6.14M | -534.38%-19.39M | 172.25%9.1M | -62.37%1.53M | 10.77%2.62M | 0.15%-9.22M | -176.16%-3.06M | 15.65%-12.6M | 308.34%4.06M | 244.19%2.37M |
Income before tax | 640.24%255.6M | -108.49%-15.53M | -54.29%93.39M | 144.31%103.12M | 162.20%74.63M | -93.66%34.53M | 1,780.49%182.9M | 22.11%204.32M | -214.18%-232.71M | -173.25%-119.98M |
Income tax | -101.32%-3.36M | -97.05%1.91M | -186.57%-83.43M | -61.42%43.12M | 288.60%35.04M | 38.60%254.36M | 837.61%64.8M | 34.58%96.37M | 61.36%111.76M | -136.12%-18.58M |
Net income | 217.80%258.96M | -114.77%-17.44M | 63.79%176.82M | 117.42%60M | 139.04%39.59M | -160.87%-219.83M | 537.98%118.1M | 12.78%107.95M | -356.01%-344.47M | -190.25%-101.4M |
Net income continuous operations | 217.80%258.96M | -114.77%-17.44M | 63.79%176.82M | 117.42%60M | 139.04%39.59M | -160.87%-219.83M | 537.98%118.1M | 12.78%107.95M | -356.01%-344.47M | -190.25%-101.4M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 217.80%258.96M | -114.77%-17.44M | 63.80%176.82M | 117.42%60M | 139.04%39.59M | -160.87%-219.83M | 538.03%118.1M | 12.78%107.95M | -356.02%-344.47M | -190.25%-101.4M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 217.80%258.96M | -114.77%-17.44M | 63.80%176.82M | 117.42%60M | 139.04%39.59M | -160.87%-219.83M | 538.03%118.1M | 12.78%107.95M | -356.02%-344.47M | -190.25%-101.4M |
Gross dividend payment | ||||||||||
Basic earnings per share | 216.10%44.35 | -114.66%-3.03 | 59.62%30.28 | 117.12%10.29 | 138.39%6.81 | -159.64%-38.2 | 562.50%20.67 | 12.05%18.97 | -350.73%-60.1 | -188.57%-17.74 |
Diluted earnings per share | 213.43%43.33 | -114.88%-3.03 | 57.99%29.57 | 116.71%10.04 | 137.37%6.63 | -163.38%-38.2 | 558.80%20.3571 | 17.13%18.7167 | -367.71%-60.1 | -194.61%-17.74 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |